ALPPS Combined With Tislelizumab in Liver Malignancy

NCT04996446 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Liver Malignant Tumors

Interventions

DRUG: Tislelizumab
PROCEDURE: ALPPS surgery

Sponsor

Fudan University